SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-20-008454
Filing Date
2020-04-02
Accepted
2020-04-02 16:29:05
Documents
1
Group Members
SOOMI NIIHARA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea120361-13da1niihara_emmaus.htm SC 13D/A 73988
  Complete submission text file 0001213900-20-008454.txt   75567
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Subject) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79934 | Film No.: 20769348
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20725 S. WESTERN BLVD. SUITE 136 TORRANCE CA 90501
Business Address
Niihara Yutaka (Filed by) CIK: 0001517691 (see all company filings)

Type: SC 13D/A